Novel	JJ	B-NP	O	Other	Other	Other	Other	Other	###	1	Novel	Novel	JJ	JJ	_	2	amod	_	_
therapies	NNS	I-NP	O	Other	Other	Other	Other	Other	###	2	therapies	therapies	NNS	NNS	_	0	root	_	_
for	IN	B-PP	O	Other	Other	Other	Other	Other	###	3	for	for	IN	IN	_	6	case	_	_
inflammatory	JJ	B-NP	O	Other	Other	Other	Other	Other	###	4	inflammatory	inflammatory	JJ	JJ	_	6	amod	_	_
bowel	NN	I-NP	O	Other	Other	Other	Other	Other	###	5	bowel	bowel	NN	NN	_	6	compound	_	_
disease	NN	I-NP	O	Other	Other	Other	Other	Other	###	6	disease	disease	NN	NN	_	2	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	7	.	.	.	.	_	2	punct	_	_

Looking	VBG	B-VP	O	Other	Other	Other	Other	Other	###	1	Looking	Looking	VBG	VBG	_	16	advcl	_	_
back	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	2	back	back	RB	RB	_	1	advmod	_	_
at	IN	B-PP	O	Other	Other	Other	Other	Other	###	3	at	at	IN	IN	_	4	case	_	_
successes	NNS	B-NP	O	Other	Other	Other	Other	Other	###	4	successes	successes	NNS	NNS	_	1	nmod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	5	and	and	CC	CC	_	4	cc	_	_
failures	NNS	I-NP	O	Other	Other	Other	Other	Other	###	6	failures	failures	NNS	NNS	_	4	conj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	in	in	IN	IN	_	9	case	_	_
newer	JJR	B-NP	O	Other	Other	Other	Other	Other	###	8	newer	newer	JJR	JJR	_	9	amod	_	_
approaches	NNS	I-NP	O	Other	Other	Other	Other	Other	###	9	approaches	approaches	NNS	NNS	_	4	nmod	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	10	to	to	TO	TO	_	11	mark	_	_
treating	VBG	B-VP	O	Other	Other	Other	Other	Other	###	11	treating	treating	VBG	VBG	_	9	acl	_	_
IBD	NN	B-NP	O	Other	Other	Other	Other	Other	###	12	IBD	IBD	NN	NN	_	11	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	13	,	,	,	,	_	16	punct	_	_
it	PRP	B-NP	O	Other	Other	Other	Other	Other	###	14	it	it	PRP	PRP	_	16	nsubj	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	15	is	is	VBZ	VBZ	_	16	cop	_	_
tempting	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	16	tempting	tempting	JJ	JJ	_	0	root	_	_
--	:	O	O	Other	Other	Other	Other	Other	###	17	--	--	:	:	_	16	punct	_	_
although	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	18	although	although	IN	IN	_	20	mark	_	_
still	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	19	still	still	RB	RB	_	20	advmod	_	_
difficult	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	20	difficult	difficult	JJ	JJ	_	16	dep	_	_
--	:	O	O	Other	Other	Other	Other	Other	###	21	--	--	:	:	_	20	punct	_	_
to	TO	B-VP	O	Other	Other	Other	Other	Other	###	22	to	to	TO	TO	_	23	mark	_	_
draw	VB	I-VP	O	Other	Other	Other	Other	Other	###	23	draw	draw	VB	VB	_	16	xcomp	_	_
conclusions	NNS	B-NP	O	Other	Other	Other	Other	Other	###	24	conclusions	conclusions	NNS	NNS	_	23	dobj	_	_
about	IN	B-PP	O	Other	Other	Other	Other	Other	###	25	about	about	IN	IN	_	26	case	_	_
pathogenesis	NN	B-NP	O	Other	Other	Other	Other	Other	###	26	pathogenesis	pathogenesis	NN	NN	_	24	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	27	.	.	.	.	_	16	punct	_	_

When	WRB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	When	When	WRB	WRB	_	4	advmod	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	2	a	a	DT	DT	_	3	det	_	_
therapy	NN	I-NP	O	Other	Other	Other	Other	Other	###	3	therapy	therapy	NN	NN	_	4	nsubj	_	_
proves	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	4	proves	proves	VBZ	VBZ	_	10	advcl	_	_
effective	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	5	effective	effective	JJ	JJ	_	4	xcomp	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	6	,	,	,	,	_	10	punct	_	_
do	VBP	B-VP	O	Other	Other	Other	Other	Other	###	7	do	do	VBP	VBP	_	10	aux	_	_
clinicians	NNS	B-NP	O	Other	Other	Other	Other	Other	###	8	clinicians	clinicians	NNS	NNS	_	10	nsubj	_	_
truly	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	9	truly	truly	RB	RB	_	10	advmod	_	_
know	VBP	B-VP	O	Other	Other	Other	Other	Other	###	10	know	know	VBP	VBP	_	0	root	_	_
how	WRB	B-ADVP	O	Other	Other	Other	Other	Other	###	11	how	how	WRB	WRB	_	13	advmod	_	_
it	PRP	B-NP	O	Other	Other	Other	Other	Other	###	12	it	it	PRP	PRP	_	13	nsubj	_	_
works	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	13	works	works	VBZ	VBZ	_	10	ccomp	_	_
?	.	O	O	Other	Other	Other	Other	Other	###	14	?	?	.	.	_	10	punct	_	_

Even	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	Even	Even	RB	RB	_	14	advcl	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	2	with	with	IN	IN	_	4	case	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	3	a	a	DT	DT	_	4	det	_	_
therapy	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	therapy	therapy	NN	NN	_	1	nmod	_	_
as	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	as	as	IN	IN	_	6	dep	_	_
specific	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	6	specific	specific	JJ	JJ	_	4	amod	_	_
as	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	as	as	IN	IN	_	9	case	_	_
anti-TNF	JJ	B-NP	B-protein	Other	Other	Other	Other	Other	###	8	anti-TNF	anti-TNF	JJ	JJ	_	9	amod	_	_
antibody	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	9	antibody	antibody	NN	NN	_	6	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	10	,	,	,	,	_	14	punct	_	_
it	PRP	B-NP	O	Other	Other	Other	Other	Other	###	11	it	it	PRP	PRP	_	14	nsubj	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	12	is	is	VBZ	VBZ	_	14	cop	_	_
not	RB	O	O	Other	Other	Other	Other	Other	###	13	not	not	RB	RB	_	14	neg	_	_
clear	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	14	clear	clear	JJ	JJ	_	0	root	_	_
if	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	15	if	if	IN	IN	_	19	mark	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	16	the	the	DT	DT	_	17	det	_	_
benefit	NN	I-NP	O	Other	Other	Other	Other	Other	###	17	benefit	benefit	NN	NN	_	19	nsubj	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	18	is	is	VBZ	VBZ	_	19	cop	_	_
attributable	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	19	attributable	attributable	JJ	JJ	_	14	advcl	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	20	to	to	TO	TO	_	22	case	_	_
simple	JJ	B-NP	O	Other	Other	Other	Other	Other	###	21	simple	simple	JJ	JJ	_	22	amod	_	_
binding	NN	I-NP	O	Other	Other	Other	Other	B-Binding	###	22	binding	binding	NN	NN	_	19	nmod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	23	and	and	CC	CC	_	22	cc	_	_
clearance	NN	I-NP	O	Other	Other	Other	Other	Other	###	24	clearance	clearance	NN	NN	_	22	conj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	25	of	of	IN	IN	_	26	case	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	26	TNF-alpha	TNF-alpha	NN	NN	_	22	nmod	_	_
or	CC	B-PP	O	Other	Other	Other	Other	Other	###	27	or	or	CC	CC	_	22	cc	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	28	to	to	TO	TO	_	29	case	_	_
binding	NN	B-NP	O	Other	Other	Other	Other	Other	###	29	binding	binding	NN	NN	_	22	conj	_	_
on	IN	B-PP	O	Other	Other	Other	Other	Other	###	30	on	on	IN	IN	_	33	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	31	the	the	DT	DT	_	33	det	_	_
cell	NN	I-NP	O	Other	Other	Other	Other	Other	###	32	cell	cell	NN	NN	_	33	compound	_	_
surface	NN	I-NP	O	Other	Other	Other	Other	Other	###	33	surface	surface	NN	NN	_	29	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	34	and	and	CC	CC	_	29	cc	_	_
subsequent	JJ	B-NP	O	Other	Other	Other	Other	Other	###	35	subsequent	subsequent	JJ	JJ	_	36	amod	_	_
deletion	NN	I-NP	O	Other	Other	Other	Other	Other	###	36	deletion	deletion	NN	NN	_	29	conj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	37	of	of	IN	IN	_	40	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	38	the	the	DT	DT	_	40	det	_	_
activated	VBN	I-NP	B-cell_type	Other	Other	Other	Other	Other	###	39	activated	activated	VBN	VBN	_	40	amod	_	_
macrophage	NN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	40	macrophage	macrophage	NN	NN	_	36	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	41	.	.	.	.	_	14	punct	_	_

When	WRB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	When	When	WRB	WRB	_	4	advmod	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	2	a	a	DT	DT	_	3	det	_	_
drug	NN	I-NP	O	Other	Other	Other	Other	Other	###	3	drug	drug	NN	NN	_	4	nsubj	_	_
appears	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	4	appears	appears	VBZ	VBZ	_	23	advcl	_	_
to	TO	I-VP	O	Other	Other	Other	Other	Other	###	5	to	to	TO	TO	_	8	mark	_	_
be	VB	I-VP	O	Other	Other	Other	Other	Other	###	6	be	be	VB	VB	_	8	cop	_	_
less	RBR	B-ADJP	O	Other	Other	Other	Other	Other	###	7	less	less	RBR	RBR	_	8	advmod	_	_
effective	JJ	I-ADJP	O	Other	Other	Other	Other	Other	###	8	effective	effective	JJ	JJ	_	4	xcomp	_	_
than	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	than	than	IN	IN	_	12	mark	_	_
preclinical	JJ	B-NP	O	Other	Other	Other	Other	Other	###	10	preclinical	preclinical	JJ	JJ	_	11	amod	_	_
models	NNS	I-NP	O	Other	Other	Other	Other	Other	###	11	models	models	NNS	NNS	_	12	nsubj	_	_
suggest	VBP	B-VP	O	Other	Other	Other	Other	Other	###	12	suggest	suggest	VBP	VBP	_	8	ccomp	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	13	,	,	,	,	_	23	punct	_	_
can	MD	B-VP	O	Other	Other	Other	Other	Other	###	14	can	can	MD	MD	_	23	aux	_	_
failures	NNS	B-NP	O	Other	Other	Other	Other	Other	###	15	failures	failures	NNS	NNS	_	23	nsubjpass	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	16	in	in	IN	IN	_	17	case	_	_
effectiveness	NN	B-NP	O	Other	Other	Other	Other	Other	###	17	effectiveness	effectiveness	NN	NN	_	15	nmod	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	18	from	from	IN	IN	_	19	case	_	_
delivery	NN	B-NP	O	Other	Other	Other	Other	Other	###	19	delivery	delivery	NN	NN	_	17	nmod	_	_
or	CC	I-NP	O	Other	Other	Other	Other	Other	###	20	or	or	CC	CC	_	19	cc	_	_
dosing	NN	I-NP	O	Other	Other	Other	Other	Other	###	21	dosing	dosing	NN	NN	_	19	conj	_	_
be	VB	B-VP	O	Other	Other	Other	Other	Other	###	22	be	be	VB	VB	_	23	auxpass	_	_
differentiated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	23	differentiated	differentiated	VBN	VBN	_	0	root	_	_
?	.	O	O	Other	Other	Other	Other	Other	###	24	?	?	.	.	_	23	punct	_	_

The	DT	B-NP	O	Other	Other	Other	Other	Other	###	1	The	The	DT	DT	_	3	det	_	_
disappointing	JJ	I-NP	O	Other	Other	Other	Other	Other	###	2	disappointing	disappointing	JJ	JJ	_	3	amod	_	_
results	NNS	I-NP	O	Other	Other	Other	Other	Other	###	3	results	results	NNS	NNS	_	22	nsubj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	4	of	of	IN	IN	_	6	case	_	_
clinical	JJ	B-NP	O	Other	Other	Other	Other	Other	###	5	clinical	clinical	JJ	JJ	_	6	amod	_	_
trials	NNS	I-NP	O	Other	Other	Other	Other	Other	###	6	trials	trials	NNS	NNS	_	3	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	with	with	IN	IN	_	8	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	Other	Other	Other	Other	###	8	IL-10	IL-10	NN	NN	_	6	nmod	_	_
--	:	O	O	Other	Other	Other	Other	Other	###	9	--	--	:	:	_	3	punct	_	_
so	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	10	so	so	RB	RB	_	15	dep	_	_
at	IN	B-PP	O	Other	Other	Other	Other	Other	###	11	at	at	IN	IN	_	15	case	_	_
odds	NNS	B-NP	O	Other	Other	Other	Other	Other	###	12	odds	odds	NNS	NNS	_	15	dep	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	13	with	with	IN	IN	_	15	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	14	the	the	DT	DT	_	15	det	_	_
prediction	NN	I-NP	O	Other	Other	Other	Other	Other	###	15	prediction	prediction	NN	NN	_	3	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	16	of	of	IN	IN	_	17	case	_	_
benefit	NN	B-NP	O	Other	Other	Other	Other	Other	###	17	benefit	benefit	NN	NN	_	15	nmod	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	18	from	from	IN	IN	_	20	case	_	_
animal	NN	B-NP	O	Other	Other	Other	Other	Other	###	19	animal	animal	NN	NN	_	20	compound	_	_
models	NNS	I-NP	O	Other	Other	Other	Other	Other	###	20	models	models	NNS	NNS	_	17	nmod	_	_
--	:	O	O	Other	Other	Other	Other	Other	###	21	--	--	:	:	_	3	punct	_	_
bring	VBP	B-VP	O	Other	Other	Other	Other	Other	###	22	bring	bring	VBP	VBP	_	0	root	_	_
into	IN	B-PP	O	Other	Other	Other	Other	Other	###	23	into	into	IN	IN	_	24	case	_	_
question	NN	B-NP	O	Other	Other	Other	Other	Other	###	24	question	question	NN	NN	_	22	nmod	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	25	the	the	DT	DT	_	26	det	_	_
validity	NN	I-NP	O	Other	Other	Other	Other	Other	###	26	validity	validity	NN	NN	_	22	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	27	of	of	IN	IN	_	29	case	_	_
those	DT	B-NP	O	Other	Other	Other	Other	Other	###	28	those	those	DT	DT	_	29	det	_	_
models	NNS	I-NP	O	Other	Other	Other	Other	Other	###	29	models	models	NNS	NNS	_	26	nmod	_	_
as	RB	B-CONJP	O	Other	Other	Other	Other	Other	###	30	as	as	RB	RB	_	26	cc	_	_
well	RB	I-CONJP	O	Other	Other	Other	Other	Other	###	31	well	well	RB	RB	_	30	mwe	_	_
as	IN	I-CONJP	O	Other	Other	Other	Other	Other	###	32	as	as	IN	IN	_	30	mwe	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	33	the	the	DT	DT	_	34	det	_	_
soundness	NN	I-NP	O	Other	Other	Other	Other	Other	###	34	soundness	soundness	NN	NN	_	26	conj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	35	of	of	IN	IN	_	36	case	_	_
design	NN	B-NP	O	Other	Other	Other	Other	Other	###	36	design	design	NN	NN	_	34	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	37	of	of	IN	IN	_	40	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	38	the	the	DT	DT	_	40	det	_	_
clinical	JJ	I-NP	O	Other	Other	Other	Other	Other	###	39	clinical	clinical	JJ	JJ	_	40	amod	_	_
trials	NNS	I-NP	O	Other	Other	Other	Other	Other	###	40	trials	trials	NNS	NNS	_	36	nmod	_	_
on	IN	B-PP	O	Other	Other	Other	Other	Other	###	41	on	on	IN	IN	_	42	case	_	_
which	WDT	B-NP	O	Other	Other	Other	Other	Other	###	42	which	which	WDT	WDT	_	47	nmod	_	_
efficacy	NN	B-NP	O	Other	Other	Other	Other	Other	###	43	efficacy	efficacy	NN	NN	_	47	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	44	of	of	IN	IN	_	45	case	_	_
IL-10	NN	B-NP	B-protein	B-Protein	Other	Other	Other	Other	###	45	IL-10	IL-10	NN	NN	_	43	nmod	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	46	is	is	VBZ	VBZ	_	47	auxpass	_	_
judged	VBN	I-VP	O	Other	Other	Other	Other	Other	###	47	judged	judged	VBN	VBN	_	40	acl:relcl	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	48	.	.	.	.	_	22	punct	_	_

The	DT	B-NP	O	Other	Other	Other	Other	Other	###	1	The	The	DT	DT	_	2	det	_	_
variability	NN	I-NP	O	Other	Other	Other	Other	Other	###	2	variability	variability	NN	NN	_	12	nsubj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	3	of	of	IN	IN	_	4	case	_	_
response	NN	B-NP	O	Other	Other	Other	Other	Other	###	4	response	response	NN	NN	_	2	nmod	_	_
even	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	5	even	even	RB	RB	_	4	acl	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	6	to	to	TO	TO	_	11	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	7	the	the	DT	DT	_	11	det	_	_
most	RBS	I-NP	O	Other	Other	Other	Other	Other	###	8	most	most	RBS	RBS	_	9	advmod	_	_
narrowly	RB	I-NP	O	Other	Other	Other	Other	Other	###	9	narrowly	narrowly	RB	RB	_	11	advmod	_	_
targeted	VBN	I-NP	O	Other	Other	Other	Other	Other	###	10	targeted	targeted	VBN	VBN	_	11	amod	_	_
agents	NNS	I-NP	O	Other	Other	Other	Other	Other	###	11	agents	agents	NNS	NNS	_	5	nmod	_	_
suggests	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	12	suggests	suggests	VBZ	VBZ	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	13	that	that	IN	IN	_	19	mark	_	_
these	DT	B-NP	O	Other	Other	Other	Other	Other	###	14	these	these	DT	DT	_	15	det	_	_
diseases	NNS	I-NP	O	Other	Other	Other	Other	Other	###	15	diseases	diseases	NNS	NNS	_	19	nsubj	_	_
are	VBP	B-VP	O	Other	Other	Other	Other	Other	###	16	are	are	VBP	VBP	_	19	cop	_	_
far	RB	B-ADJP	O	Other	Other	Other	Other	Other	###	17	far	far	RB	RB	_	18	advmod	_	_
more	RBR	I-ADJP	O	Other	Other	Other	Other	Other	###	18	more	more	RBR	RBR	_	19	advmod	_	_
heterogeneous	JJ	I-ADJP	O	Other	Other	Other	Other	Other	###	19	heterogeneous	heterogeneous	JJ	JJ	_	12	ccomp	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	20	in	in	IN	IN	_	21	case	_	_
humans	NNS	B-NP	O	Other	Other	Other	Other	Other	###	21	humans	humans	NNS	NNS	_	19	nmod	_	_
than	IN	B-PP	O	Other	Other	Other	Other	Other	###	22	than	than	IN	IN	_	26	case	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	23	in	in	IN	IN	_	26	case	_	_
their	PRP$	B-NP	O	Other	Other	Other	Other	Other	###	24	their	their	PRP$	PRP$	_	26	nmod:poss	_	_
murine	JJ	I-NP	B-protein	Other	Other	Other	Other	Other	###	25	murine	murine	JJ	JJ	_	26	amod	_	_
counterparts	NNS	I-NP	I-protein	Other	Other	Other	Other	Other	###	26	counterparts	counterparts	NNS	NNS	_	19	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	27	.	.	.	.	_	12	punct	_	_

Clinicians	NNS	B-NP	O	Other	Other	Other	Other	Other	###	1	Clinicians	Clinicians	NNS	NNS	_	5	nsubj	_	_
are	VBP	B-VP	O	Other	Other	Other	Other	Other	###	2	are	are	VBP	VBP	_	5	cop	_	_
only	RB	I-VP	O	Other	Other	Other	Other	Other	###	3	only	only	RB	RB	_	4	advmod	_	_
just	RB	I-VP	O	Other	Other	Other	Other	Other	###	4	just	just	RB	RB	_	5	advmod	_	_
beginning	VBG	I-VP	O	Other	Other	Other	Other	Other	###	5	beginning	beginning	VBG	VBG	_	0	root	_	_
to	TO	I-VP	O	Other	Other	Other	Other	Other	###	6	to	to	TO	TO	_	7	mark	_	_
recognize	VB	I-VP	O	Other	Other	Other	Other	Other	###	7	recognize	recognize	VB	VB	_	5	xcomp	_	_
subclinical	JJ	B-NP	O	Other	Other	Other	Other	Other	###	8	subclinical	subclinical	JJ	JJ	_	9	amod	_	_
markers	NNS	I-NP	O	Other	Other	Other	Other	Other	###	9	markers	markers	NNS	NNS	_	7	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	of	of	IN	IN	_	11	case	_	_
response	NN	B-NP	O	Other	Other	Other	Other	Other	###	11	response	response	NN	NN	_	9	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	12	,	,	,	,	_	5	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	13	and	and	CC	CC	_	5	cc	_	_
it	PRP	B-NP	O	Other	Other	Other	Other	Other	###	14	it	it	PRP	PRP	_	18	nsubj	_	_
may	MD	B-VP	O	Other	Other	Other	Other	Other	###	15	may	may	MD	MD	_	18	aux	_	_
soon	RB	I-VP	O	Other	Other	Other	Other	Other	###	16	soon	soon	RB	RB	_	18	advmod	_	_
be	VB	I-VP	O	Other	Other	Other	Other	Other	###	17	be	be	VB	VB	_	18	cop	_	_
possible	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	18	possible	possible	JJ	JJ	_	5	conj	_	_
to	TO	B-VP	O	Other	Other	Other	Other	Other	###	19	to	to	TO	TO	_	20	mark	_	_
predict	VB	I-VP	O	Other	Other	Other	Other	Other	###	20	predict	predict	VB	VB	_	18	xcomp	_	_
response	NN	B-NP	O	Other	Other	Other	Other	Other	###	21	response	response	NN	NN	_	20	dobj	_	_
on	IN	B-PP	O	Other	Other	Other	Other	Other	###	22	on	on	IN	IN	_	24	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	23	the	the	DT	DT	_	24	det	_	_
basis	NN	I-NP	O	Other	Other	Other	Other	Other	###	24	basis	basis	NN	NN	_	21	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	25	of	of	IN	IN	_	27	case	_	_
genetic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	26	genetic	genetic	JJ	JJ	_	27	amod	_	_
composition	NN	I-NP	O	Other	Other	Other	Other	Other	###	27	composition	composition	NN	NN	_	24	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	28	.	.	.	.	_	5	punct	_	_

For	IN	B-PP	O	Other	Other	Other	Other	Other	###	1	For	For	IN	IN	_	3	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	2	the	the	DT	DT	_	3	det	_	_
moment	NN	I-NP	O	Other	Other	Other	Other	Other	###	3	moment	moment	NN	NN	_	12	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	4	,	,	,	,	_	12	punct	_	_
however	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	5	however	however	RB	RB	_	12	advmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	6	,	,	,	,	_	12	punct	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	7	the	the	DT	DT	_	8	det	_	_
field	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	field	field	NN	NN	_	12	nsubj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	of	of	IN	IN	_	10	case	_	_
pharmacogenetics	NNS	B-NP	O	Other	Other	Other	Other	Other	###	10	pharmacogenetics	pharmacogenetics	NNS	NNS	_	8	nmod	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	11	is	is	VBZ	VBZ	_	12	cop	_	_
embryonic	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	12	embryonic	embryonic	JJ	JJ	_	0	root	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	13	.	.	.	.	_	12	punct	_	_

Challenges	NNS	B-NP	O	Other	Other	Other	Other	Other	###	1	Challenges	Challenges	NNS	NNS	_	7	nsubj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	2	in	in	IN	IN	_	3	mark	_	_
developing	VBG	B-VP	O	Other	Other	Other	Other	Other	###	3	developing	developing	VBG	VBG	_	1	acl	_	_
new	JJ	B-NP	O	Other	Other	Other	Other	Other	###	4	new	new	JJ	JJ	_	6	amod	_	_
therapeutic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	5	therapeutic	therapeutic	JJ	JJ	_	4	dep	_	_
strategies	NNS	I-NP	O	Other	Other	Other	Other	Other	###	6	strategies	strategies	NNS	NNS	_	3	dobj	_	_
include	VBP	B-VP	O	Other	Other	Other	Other	Other	###	7	include	include	VBP	VBP	_	0	root	_	_
not	RB	B-CONJP	O	Other	Other	Other	Other	Other	###	8	not	not	RB	RB	_	9	neg	_	_
only	RB	I-CONJP	O	Other	Other	Other	Other	Other	###	9	only	only	RB	RB	_	10	advmod	_	_
identifying	VBG	B-VP	O	Other	Other	Other	Other	Other	###	10	identifying	identifying	VBG	VBG	_	7	xcomp	_	_
novel	JJ	B-NP	O	Other	Other	Other	Other	Other	###	11	novel	novel	JJ	JJ	_	12	amod	_	_
agents	NNS	I-NP	O	Other	Other	Other	Other	Other	###	12	agents	agents	NNS	NNS	_	10	dobj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	13	,	,	,	,	_	10	punct	_	_
but	CC	O	O	Other	Other	Other	Other	Other	###	14	but	but	CC	CC	_	10	cc	_	_
also	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	15	also	also	RB	RB	_	16	advmod	_	_
improving	VBG	B-VP	O	Other	Other	Other	Other	Other	###	16	improving	improving	VBG	VBG	_	10	conj	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	17	the	the	DT	DT	_	18	det	_	_
definitions	NNS	I-NP	O	Other	Other	Other	Other	Other	###	18	definitions	definitions	NNS	NNS	_	16	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	19	of	of	IN	IN	_	21	case	_	_
clinical	JJ	B-NP	O	Other	Other	Other	Other	Other	###	20	clinical	clinical	JJ	JJ	_	21	amod	_	_
endpoints	NNS	I-NP	O	Other	Other	Other	Other	Other	###	21	endpoints	endpoints	NNS	NNS	_	18	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	22	and	and	CC	CC	_	16	cc	_	_
defining	VBG	B-VP	O	Other	Other	Other	Other	Other	###	23	defining	defining	VBG	VBG	_	16	conj	_	_
efficacy	NN	B-NP	O	Other	Other	Other	Other	Other	###	24	efficacy	efficacy	NN	NN	_	23	dobj	_	_
at	IN	B-PP	O	Other	Other	Other	Other	Other	###	25	at	at	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	26	the	the	DT	DT	_	28	det	_	_
biologic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	27	biologic	biologic	JJ	JJ	_	28	amod	_	_
level	NN	I-NP	O	Other	Other	Other	Other	Other	###	28	level	level	NN	NN	_	23	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	29	.	.	.	.	_	7	punct	_	_

Only	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	Only	Only	RB	RB	_	10	nmod	_	_
through	IN	B-PP	O	Other	Other	Other	Other	Other	###	2	through	through	IN	IN	_	4	case	_	_
considered	VBN	B-NP	O	Other	Other	Other	Other	Other	###	3	considered	considered	VBN	VBN	_	4	amod	_	_
evaluation	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	evaluation	evaluation	NN	NN	_	1	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	5	of	of	IN	IN	_	7	case	_	_
clinical	JJ	B-NP	O	Other	Other	Other	Other	Other	###	6	clinical	clinical	JJ	JJ	_	7	amod	_	_
evidence	NN	I-NP	O	Other	Other	Other	Other	Other	###	7	evidence	evidence	NN	NN	_	4	nmod	_	_
may	MD	B-VP	O	Other	Other	Other	Other	Other	###	8	may	may	MD	MD	_	10	aux	_	_
clinicians	NNS	B-NP	O	Other	Other	Other	Other	Other	###	9	clinicians	clinicians	NNS	NNS	_	10	nsubj	_	_
determine	VB	B-VP	O	Other	Other	Other	Other	Other	###	10	determine	determine	VB	VB	_	0	root	_	_
which	WDT	B-NP	O	Other	Other	Other	Other	Other	###	11	which	which	WDT	WDT	_	12	det	_	_
therapies	NNS	I-NP	O	Other	Other	Other	Other	Other	###	12	therapies	therapies	NNS	NNS	_	14	nsubj	_	_
should	MD	B-VP	O	Other	Other	Other	Other	Other	###	13	should	should	MD	MD	_	14	aux	_	_
remain	VB	I-VP	O	Other	Other	Other	Other	Other	###	14	remain	remain	VB	VB	_	10	ccomp	_	_
novelties	NNS	B-NP	O	Other	Other	Other	Other	Other	###	15	novelties	novelties	NNS	NNS	_	14	xcomp	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	16	and	and	CC	CC	_	14	cc	_	_
which	WDT	B-NP	O	Other	Other	Other	Other	Other	###	17	which	which	WDT	WDT	_	19	nsubj	_	_
should	MD	B-VP	O	Other	Other	Other	Other	Other	###	18	should	should	MD	MD	_	19	aux	_	_
become	VB	I-VP	O	Other	Other	Other	Other	Other	###	19	become	become	VB	VB	_	14	conj	_	_
an	DT	B-NP	O	Other	Other	Other	Other	Other	###	20	an	an	DT	DT	_	22	det	_	_
accepted	VBN	I-NP	O	Other	Other	Other	Other	Other	###	21	accepted	accepted	VBN	VBN	_	22	amod	_	_
part	NN	I-NP	O	Other	Other	Other	Other	Other	###	22	part	part	NN	NN	_	19	xcomp	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	23	of	of	IN	IN	_	25	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	24	the	the	DT	DT	_	25	det	_	_
armamentarium	NN	I-NP	O	Other	Other	Other	Other	Other	###	25	armamentarium	armamentarium	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	26	.	.	.	.	_	10	punct	_	_

